Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. This process has identified multiple inconsistencies in the diagnostic criteria and lack of clear guidelines for the staging and treatment. The authors of this review have held several meetings and exchanged series of cases with the objective of agreeing on the main diagnostic, staging and therapeutic guidelines for patients with this condition. Specific working groups were created for diagnostic criteria, immunophenotype, staging and treatment. As results of this work, guidelines are proposed for diagnosis, differential diagnosis, staging, prognostic factors, treatment and response criteria. The guidelines proposed here are intended to contribute to the standardization of the diagnosis and treatment of these patients, and should facilitate the future development of clinical trials that could define more precisely predictive markers for histological progression or lack of response, and evaluate new drugs or treatments

MATUTES E, OSCIER D, MONTALBAN C, BERGER F, CALLET-BAUCHU E, DOGAN A, et al. (2008). Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. LEUKEMIA, 22(3), 487-495 [10.1038/sj.leu.2405068].

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

FRANCO, Vito;
2008-01-01

Abstract

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. This process has identified multiple inconsistencies in the diagnostic criteria and lack of clear guidelines for the staging and treatment. The authors of this review have held several meetings and exchanged series of cases with the objective of agreeing on the main diagnostic, staging and therapeutic guidelines for patients with this condition. Specific working groups were created for diagnostic criteria, immunophenotype, staging and treatment. As results of this work, guidelines are proposed for diagnosis, differential diagnosis, staging, prognostic factors, treatment and response criteria. The guidelines proposed here are intended to contribute to the standardization of the diagnosis and treatment of these patients, and should facilitate the future development of clinical trials that could define more precisely predictive markers for histological progression or lack of response, and evaluate new drugs or treatments
2008
Settore MED/08 - Anatomia Patologica
MATUTES E, OSCIER D, MONTALBAN C, BERGER F, CALLET-BAUCHU E, DOGAN A, et al. (2008). Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. LEUKEMIA, 22(3), 487-495 [10.1038/sj.leu.2405068].
File in questo prodotto:
File Dimensione Formato  
Splenic marginal.pdf

Solo gestori archvio

Dimensione 127.91 kB
Formato Adobe PDF
127.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/25688
Citazioni
  • ???jsp.display-item.citation.pmc??? 58
  • Scopus 219
  • ???jsp.display-item.citation.isi??? 185
social impact